These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11968741)

  • 41. Clinical application of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: comparison with brain perfusion SPECT.
    Takahashi H; Ishii K; Hosokawa C; Hyodo T; Kashiwagi N; Matsuki M; Ashikaga R; Murakami T
    AJNR Am J Neuroradiol; 2014 May; 35(5):906-11. PubMed ID: 24263694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign.
    Bonte FJ; Harris TS; Roney CA; Hynan LS
    J Nucl Med; 2004 May; 45(5):771-4. PubMed ID: 15136625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease.
    Hashikawa K; Matsumoto M; Moriwaki H; Oku N; Okazaki Y; Seike Y; Uehara T; Tanabe H; Ohie Y; Kamada T
    J Nucl Med; 1995 Apr; 36(4):690-6. PubMed ID: 7699466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.
    Bartenstein P; Minoshima S; Hirsch C; Buch K; Willoch F; Mösch D; Schad D; Schwaiger M; Kurz A
    J Nucl Med; 1997 Jul; 38(7):1095-101. PubMed ID: 9225797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebral blood flow reduction associated with orientation for time in amnesic mild cognitive impairment and Alzheimer disease patients.
    Yamashita KI; Taniwaki Y; Utsunomiya H; Taniwaki T
    J Neuroimaging; 2014; 24(6):590-594. PubMed ID: 24593247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical utility of the normal database of
    Yamazaki T; Inui Y; Ichihara T; Uno M; Ota S; Toyoda A; Ishiguro M; Kato T; Ito K; Toyama H
    Ann Nucl Med; 2019 Nov; 33(11):835-841. PubMed ID: 31414335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease.
    Ashford JW; Shih WJ; Coupal J; Shetty R; Schneider A; Cool C; Aleem A; Kiefer VH; Mendiondo MS; Schmitt FA
    J Nucl Med; 2000 Jan; 41(1):57-64. PubMed ID: 10647605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of anatomical normalization errors in SPM and 3D-SSP using digital brain phantom.
    Onishi H; Matsutake Y; Kawashima H; Matsutomo N; Amijima H
    Ann Nucl Med; 2011 Jan; 25(1):59-67. PubMed ID: 21153453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute brain infarction clearly demonstrated by using the three-dimensional stereotactic surface projections (3D-SSP) of 99mTc-HMPAO SPECT].
    Hyon B; Moriwaki H; Rai M; Hayashida K; Naritomi H
    Rinsho Shinkeigaku; 2004 Sep; 44(9):626-9. PubMed ID: 15515708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
    Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
    Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
    Julin P; Lindqvist J; Svensson L; Slomka P; Wahlund LO
    J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Sakurai H; Iwamoto T; Koizumi K; Abe K
    J Neurol Sci; 2006 Dec; 250(1-2):97-102. PubMed ID: 17005204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT.
    Kanetaka H; Matsuda H; Asada T; Ohnishi T; Yamashita F; Imabayashi E; Tanaka F; Nakano S; Takasaki M
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):975-80. PubMed ID: 14991240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional cerebral blood flow difference between dementia with Lewy bodies and AD.
    Ishii K; Yamaji S; Kitagaki H; Imamura T; Hirono N; Mori E
    Neurology; 1999 Jul; 53(2):413-6. PubMed ID: 10430439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.
    Kogure D; Matsuda H; Ohnishi T; Asada T; Uno M; Kunihiro T; Nakano S; Takasaki M
    J Nucl Med; 2000 Jul; 41(7):1155-62. PubMed ID: 10914904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Alzheimer's disease with vascular dementia and non-dementia using specific voxel-based Z score maps.
    Ishii S; Shishido F; Miyajima M; Sakuma K; Shigihara T; Tameta T; Miyazaki M; Kuroda H
    Ann Nucl Med; 2009 Jan; 23(1):25-31. PubMed ID: 19205835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.